Erectile dysfunction: etiology, evaluation, and treatment options.
The evaluation and treatment of male sexual dysfunction has evolved into a more extensive evaluation. This new evaluation should now include evaluation of hypogonadism, ejaculatory function, lower urinary tract symptoms, and depression. The evaluation may be readily accomplished with the use of questionnaires. The management of these entities is discussed, including the novel phosphodiesterase-5 for male erectile dysfunction. Inclusion of the partner in the evaluation and management scheme will provide added benefit and may produce a better outcome.
Seftel
Allen D
AD
Department of Urology, Case Western Reserve University, University Hospitals of Cleveland, 11100 Euclid Avenue, Cleveland, OH 44106-5046, USA. ads6@po.cwru.edu
Mohammed
Mamdouh Ab
MA
Althof
Stanley E
SE
D003863:Depression / Q000150:complications / Q000628:therapy; D003866:Depressive Disorder / Q000150:complications / Q000628:therapy; D018491:Dopamine Agonists / Q000627:therapeutic use; D007172:Erectile Dysfunction / Q000175:diagnosis / Q000209:etiology / Q000523:psychology* / Q000628:therapy*; D006801:Humans; D007006:Hypogonadism / Q000150:complications / Q000628:therapy; D008297:Male; D010410:Penile Erection / Q000502:physiology; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use
D018491:Dopamine Agonists; D010726:Phosphodiesterase Inhibitors